Division of Urologic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eur Urol. 2011 Feb;59(2):235-43. doi: 10.1016/j.eururo.2010.08.043. Epub 2010 Sep 15.
Apical dissection and control of the dorsal vein complex (DVC) affects blood loss, apical positive margins, and urinary control during robot-assisted laparoscopic radical prostatectomy (RALP).
To describe technique and outcomes for athermal DVC division followed by selective suture ligation (DVC-SSL) compared with DVC suture ligation followed by athermal division (SL-DVC).
DESIGN, SETTINGS, AND PARTICIPANTS: Retrospective study of prospectively collected data from February 2008 to July 2010 for 303 SL-DVC and 240 DVC-SSL procedures.
RALP with comparison of DVC-SSL prior to anastomosis versus early SL-DVC prior to bladder-neck dissection.
Blood loss, transfusions, operative time, apical and overall positive margins, urine leaks, catheterization duration, and urinary control at 5 and 12 mo evaluated using 1) the Expanded Prostate Cancer Index (EPIC) urinary function scale and 2) continence defined as zero pads per day.
Men who underwent DVC-SSL versus SL-DVC were older (mean: 59.9 vs 57.8 yr, p<0.001), and relatively fewer white men underwent DVC-SSL versus SL-DVC (87.5% vs 96.7%, p<0.001). Operative times were also shorter for DVC-SSL versus SL-DVC (mean: 132 vs 147 min, p<0.001). Men undergoing DVC-SSL versus SL-DVC experienced greater blood loss (mean: 184.3 vs 175.6 ml, p=0.033), and one DVC-SSL versus zero SL-DVC were transfused (p=0.442). Overall (12.2% vs 12.0%, p=1.0) and apical (1.3% vs 2.7%, p=0.361) positive surgical margins were similar for DVC-SSL versus SL-DVC. Although 5-mo postoperative urinary function (mean: 72.9 vs 55.4, p<0.001) and continence (61.4% vs 39.6%, p<0.001) were better for DVC-SSL versus SL-DVC, 12-mo urinary outcomes were similar. In adjusted analyses, DVC-SSL versus SL-DVC was associated with shorter operative times (parameter estimate [PE]±standard error [SE]: 16.84±2.56, p<0.001), and better 5-mo urinary function (PE±SE: 19.93±3.09, p<0.001) and continence (odds ratio 3.39, 95% confidence interval 2.07-5.57, p<0.001).
DVC-SSL versus SL-DVC improves early urinary control and shortens operative times due to fewer instrument changes with late versus early DVC control.
在机器人辅助腹腔镜根治性前列腺切除术(RALP)中,尖部解剖和背静脉复合体(DVC)的控制会影响失血量、尖部阳性切缘和尿控。
描述与 DVC 缝合结扎(SL-DVC)相比,无热 DVC 分离后选择性缝合结扎(DVC-SSL)的技术和结果。
设计、设置和参与者:回顾性研究,对 2008 年 2 月至 2010 年 7 月前瞻性收集的数据进行分析,共纳入 303 例 SL-DVC 和 240 例 DVC-SSL 手术。
RALP,比较吻合前 DVC-SSL 与膀胱颈解剖前早期 SL-DVC。
采用 1)扩展前列腺癌指数(EPIC)尿功能量表和 2)每天零垫定义的控尿,评估失血量、输血、手术时间、尖部和整体阳性切缘、尿漏、导尿管留置时间以及术后 5 个月和 12 个月的尿控。
与 SL-DVC 相比,接受 DVC-SSL 的男性年龄更大(平均年龄:59.9 岁比 57.8 岁,p<0.001),接受 DVC-SSL 的白人男性相对较少(87.5%比 96.7%,p<0.001)。DVC-SSL 的手术时间也比 SL-DVC 短(平均 132 分钟比 147 分钟,p<0.001)。与 SL-DVC 相比,接受 DVC-SSL 的男性失血量更多(平均 184.3 毫升比 175.6 毫升,p=0.033),1 例 DVC-SSL 输血与 0 例 SL-DVC 输血(p=0.442)。DVC-SSL 与 SL-DVC 的总(12.2%比 12.0%,p=1.0)和尖部(1.3%比 2.7%,p=0.361)阳性手术切缘相似。尽管 DVC-SSL 术后 5 个月的尿功能(平均 72.9 比 55.4,p<0.001)和控尿(61.4%比 39.6%,p<0.001)优于 SL-DVC,但 12 个月的尿功能结果相似。在调整分析中,与 SL-DVC 相比,DVC-SSL 与较短的手术时间(参数估计[PE]±标准误差[SE]:16.84±2.56,p<0.001)和更好的 5 个月尿功能(PE±SE:19.93±3.09,p<0.001)和控尿(比值比 3.39,95%置信区间 2.07-5.57,p<0.001)相关。
与 SL-DVC 相比,DVC-SSL 通过晚期而非早期控制 DVC 减少器械更换次数,从而改善早期尿控并缩短手术时间。